INTERNATIONAL PATENT: MATISSE PHARMACEUTICALS B.V., STICHTING AMSTERDAM UMC FILES APPLICATION FOR "LOW ANTICOAGULANT HEPARIN FOR USE IN THE PREVENTION AND TREATMENT OF SEPSIS"

GENEVA, Oct. 19 -- MATISSE PHARMACEUTICALS B.V. (Burgemeester Lemmensstraat 3526163JT GELEEN), STICHTING AMSTERDAM UMC (De Boelelaan 11171081HV AMSTERDAM) filed a patent application (PCT/EP2025/060137) for "LOW ANTICOAGULANT HEPARIN FOR USE IN THE PREVENTION AND TREATMENT OF SEPSIS" on Apr 11, 2025. With publication no. WO/2025/215242, the details related to the patent application was published on Oct 16, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): EKHART, Peter Frank (Burgemeester Lemmensstraat 3526163JT GELEEN), SCHRIJVER, Roy Louis Johannes (Burgemeester Lemmensstraat 3526163JT GELEEN...